Resultados e vida financeiraSaúde - Farmacêutica - Biotecnologia
Acquisition or disposal of the issuer's own shares / Transaction in own shares (aggregate version)
09/11/2026 17:45
AMFPublicação imediata
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: Eurofins Share Buy-Back Programme
Weekly report on share repurchases from 02nd November to 06th November 2026
Name of the
Issuer
Identify code of the
Issuer
Transaction day
Identify code of the financial instrument
Total daily volume (in number of shares)
Daily weighted average purchase price of the shares
Market
(MIC
Code)
EUROFINS
SCIENTIFIC 529900JEHFM47DYY3S57 02/11/2026 FR0014000MR3 840 87.9803 CEUX
EUROFINS
SCIENTIFIC 529900JEHFM47DYY3S57 02/11/2026 FR0014000MR3 9 160 88.4369 XPAR
EUROFINS
SCIENTIFIC 529900JEHFM47DYY3S57 03/11/2026 FR0014000MR3 10 000 87.1740 XPAR
EUROFINS
SCIENTIFIC 529900JEHFM47DYY3S57 04/11/2026 FR0014000MR3 10 000 88.0649 XPAR
EUROFINS
SCIENTIFIC 529900JEHFM47DYY3S57 05/11/2026 FR0014000MR3 10 000 88.6542 XPAR
EUROFINS
SCIENTIFIC 529900JEHFM47DYY3S57 06/11/2026 FR0014000MR3 10 000 87.6419 XPAR
TOTAL 50 000 87.9867
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: Eurofins Share Buy-Back Programme
Publication réglementée diffusée via info-financière (AMF). Type : Informations réglementées continues Sous-type : Acquisition ou cession des actions de l'émetteur ISIN : FR0014000MR3 Diffuseur : BWR
Le document officiel est disponible en lien.